首页> 中文期刊> 《药学学报(英文版)》 >Repurposing vitamin D for treatment of human malignancies via targeting tumor microenvironment

Repurposing vitamin D for treatment of human malignancies via targeting tumor microenvironment

         

摘要

Tumor cells along with a small proportion of cancer stem cells exist in a stromal microenvironment consisting of vasculature,cancer-associated fibroblasts,immune cells and extracellular components.Recent epidemiological and clinical studies strongly support that vitamin D supplementation is associated with reduced cancer risk and favorable prognosis.Experimental results suggest that vitamin D not only suppresses cancer cells,but also regulates tumor microenvironment to facilitate tumor repression.In this review,we have outlined the current knowledge on epidemiological studies and clinical trials of vitamin D.Notably,we summarized and discussed the anticancer action of vitamin D in cancer cells,cancer stem cells and stroma cells in tumor microenvironment,providing a better understanding of the role of vitamin D in cancer.We presently re-propose vitamin D to be a novel and economical anticancer agent.

著录项

  • 来源
    《药学学报(英文版)》 |2019年第2期|203-219|共17页
  • 作者单位

    Laboratory of Molecular Pharmacology, Department of Pharmacology, School of Pharmacy, Southwest Medical University, Luzhou 646000, China;

    Laboratory of Molecular Pharmacology, Department of Pharmacology, School of Pharmacy, Southwest Medical University, Luzhou 646000, China;

    State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Macao,China;

    Laboratory of Molecular Pharmacology, Department of Pharmacology, School of Pharmacy, Southwest Medical University, Luzhou 646000, China;

    Laboratory of Molecular Pharmacology, Department of Pharmacology, School of Pharmacy, Southwest Medical University, Luzhou 646000, China;

    Laboratory of Molecular Pharmacology, Department of Pharmacology, School of Pharmacy, Southwest Medical University, Luzhou 646000, China;

    Department of Gastroenterology, Shenzhen Hospital, Southern Medical University, Shenzhen 518000, China;

    Sichuan Industrial Institute of Antibiotics, Chengdu University, Chengdu 610106, China;

    Laboratory of Molecular Pharmacology, Department of Pharmacology, School of Pharmacy, Southwest Medical University, Luzhou 646000, China;

    Department of Gastrointestinal Surgery, The Affiliated Hospital of Southwest Medical University, Luzhou 646000, China;

    Laboratory of Molecular Pharmacology, Department of Pharmacology, School of Pharmacy, Southwest Medical University, Luzhou 646000, China;

    Laboratory of Molecular Pharmacology, Department of Pharmacology, School of Pharmacy, Southwest Medical University, Luzhou 646000, China;

    Department of Anaesthesia and Intensive Care, The Chinese University of Hong Kong, Hong Kong, China;

    Laboratory of Molecular Pharmacology, Department of Pharmacology, School of Pharmacy, Southwest Medical University, Luzhou 646000, China;

    Laboratory of Molecular Pharmacology, Department of Pharmacology, School of Pharmacy, Southwest Medical University, Luzhou 646000, China;

  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号